Mit45

As of March 2024, the company has been the subject of a civil class action lawsuit alleging misleading sales practices and failure to disclose that kratom's active ingredients act on the same receptors as opioids, carrying risks of addiction and withdrawal.

The brand's name is derived from , the primary active alkaloid in kratom. Their product line includes: As of March 2024, the company has been

Despite its market success, MIT45 has faced significant scrutiny: As of March 2024